297 related articles for article (PubMed ID: 24233772)
41. Lactobacillus reuteri strain combination in Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study.
Francavilla R; Polimeno L; Demichina A; Maurogiovanni G; Principi B; Scaccianoce G; Ierardi E; Russo F; Riezzo G; Di Leo A; Cavallo L; Francavilla A; Versalovic J
J Clin Gastroenterol; 2014; 48(5):407-13. PubMed ID: 24296423
[TBL] [Abstract][Full Text] [Related]
42. Probiotic BIFICO cocktail ameliorates Helicobacter pylori induced gastritis.
Yu HJ; Liu W; Chang Z; Shen H; He LJ; Wang SS; Liu L; Jiang YY; Xu GT; An MM; Zhang JD
World J Gastroenterol; 2015 Jun; 21(21):6561-71. PubMed ID: 26074694
[TBL] [Abstract][Full Text] [Related]
43. Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study.
Navarro-Rodriguez T; Silva FM; Barbuti RC; Mattar R; Moraes-Filho JP; de Oliveira MN; Bogsan CS; Chinzon D; Eisig JN
BMC Gastroenterol; 2013 Mar; 13():56. PubMed ID: 23530767
[TBL] [Abstract][Full Text] [Related]
44. Effect of Bifidobacterium bifidum fermented milk on Helicobacter pylori and serum pepsinogen levels in humans.
Miki K; Urita Y; Ishikawa F; Iino T; Shibahara-Sone H; Akahoshi R; Mizusawa S; Nose A; Nozaki D; Hirano K; Nonaka C; Yokokura T
J Dairy Sci; 2007 Jun; 90(6):2630-40. PubMed ID: 17517703
[TBL] [Abstract][Full Text] [Related]
45. Are probiotics useful for therapy of Helicobacter pylori diseases?
Eslami M; Yousefi B; Kokhaei P; Jazayeri Moghadas A; Sadighi Moghadam B; Arabkari V; Niazi Z
Comp Immunol Microbiol Infect Dis; 2019 Jun; 64():99-108. PubMed ID: 31174707
[TBL] [Abstract][Full Text] [Related]
46. Inhibitory effect of Lactobacillus acidophilus on Helicobacter pylori in peptic ulcer patients: in vitro study.
Vilaichone RK; Mahachai V; Tumwasorn S; Nunthapisud P; Kullavanijaya P
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S79-84. PubMed ID: 12188456
[TBL] [Abstract][Full Text] [Related]
47. The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis.
Dang Y; Reinhardt JD; Zhou X; Zhang G
PLoS One; 2014; 9(11):e111030. PubMed ID: 25365320
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 May; 21(18):5568-74. PubMed ID: 25987781
[TBL] [Abstract][Full Text] [Related]
49.
Shen S; Ren F; Qin H; Bukhari I; Yang J; Gao D; Ouwehand AC; Lehtinen MJ; Zheng P; Mi Y
Front Cell Infect Microbiol; 2023; 13():1196084. PubMed ID: 37621875
[TBL] [Abstract][Full Text] [Related]
50. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.
Cremonini F; Di Caro S; Covino M; Armuzzi A; Gabrielli M; Santarelli L; Nista EC; Cammarota G; Gasbarrini G; Gasbarrini A
Am J Gastroenterol; 2002 Nov; 97(11):2744-9. PubMed ID: 12425542
[TBL] [Abstract][Full Text] [Related]
51. [A meta-analysis of randomized controlled trials of bismuth-containing quadruple therapy combined with probiotic supplement for eradication of
Si XB; Lan Y; Qiao L
Zhonghua Nei Ke Za Zhi; 2017 Oct; 56(10):752-759. PubMed ID: 29036957
[No Abstract] [Full Text] [Related]
52. Modified sequential therapy vs quadruple therapy as initial therapy in patients with Helicobacter infection.
Liao XM; Nong GH; Chen MZ; Huang XP; Cong YY; Huang YY; Wu BH; Wei JQ
World J Gastroenterol; 2015 May; 21(20):6310-6. PubMed ID: 26034367
[TBL] [Abstract][Full Text] [Related]
53. Living cells of probiotic Bifidobacterium bifidum YIT 10347 detected on gastric mucosa in humans.
Shibahara-Sone H; Gomi A; Iino T; Kano M; Nonaka C; Watanabe O; Miyazaki K; Ohkusa T
Benef Microbes; 2016 Jun; 7(3):319-26. PubMed ID: 26925600
[TBL] [Abstract][Full Text] [Related]
54. Rapid identification of Lactobacillus and Bifidobacterium in probiotic products using multiplex PCR.
Sul SY; Kim HJ; Kim TW; Kim HY
J Microbiol Biotechnol; 2007 Mar; 17(3):490-5. PubMed ID: 18050954
[TBL] [Abstract][Full Text] [Related]
55. Changes in the Functional Potential of the Gut Microbiome Following Probiotic Supplementation during Helicobacter Pylori Treatment.
Oh B; Kim JW; Kim BS
Helicobacter; 2016 Dec; 21(6):493-503. PubMed ID: 26991862
[TBL] [Abstract][Full Text] [Related]
56. Probiotics modulate gastrointestinal microbiota after
He C; Xie Y; Zhu Y; Zhuang K; Huo L; Yu Y; Guo Q; Shu X; Xiong Z; Zhang Z; Lyu B; Lu N
Front Immunol; 2022; 13():1033063. PubMed ID: 36426355
[TBL] [Abstract][Full Text] [Related]
57. Comparative effectiveness of different probiotics supplements for triple helicobacter pylori eradication: a network meta-analysis.
Wang Y; Wang X; Cao XY; Zhu HL; Miao L
Front Cell Infect Microbiol; 2023; 13():1120789. PubMed ID: 37256113
[TBL] [Abstract][Full Text] [Related]
58. Effect of Pretreatment with Lactobacillus delbrueckii and Streptococcus thermophillus on Tailored Triple Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial.
Tongtawee T; Dechsukhum C; Leeanansaksiri W; Kaewpitoon S; Kaewpitoon N; Loyd RA; Matrakool L; Panpimanmas S
Asian Pac J Cancer Prev; 2015; 16(12):4885-90. PubMed ID: 26163609
[TBL] [Abstract][Full Text] [Related]
59. Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial.
Tsay FW; Wu DC; Kao SS; Tsai TJ; Lai KH; Cheng JS; Chan HH; Wang HM; Tsai WL; Tseng HH; Peng NJ; Hsu PI
Helicobacter; 2015 Feb; 20(1):71-7. PubMed ID: 25495272
[TBL] [Abstract][Full Text] [Related]
60. Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis.
Zhang MM; Qian W; Qin YY; He J; Zhou YH
World J Gastroenterol; 2015 Apr; 21(14):4345-57. PubMed ID: 25892886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
